Your browser doesn't support javascript.
CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect.
Liu, Mingyue; Wang, Xu; Du, Xuexiang; Zhang, Yan; Ai, Chunxia; Hu-Lieskovan, Siwen; Li, Tianhong; Devenport, Martin; Liu, Yang; Zheng, Pan.
  • Liu M; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21202, USA.
  • Wang X; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21202, USA.
  • Du X; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21202, USA.
  • Zhang Y; Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
  • Ai C; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21202, USA.
  • Hu-Lieskovan S; Shanghai Institute of Immunology, Department of Immunology and Microbiology, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Li T; Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 21202, USA.
  • Devenport M; Key Laboratory of Infection and Immunity of Shandong Province & Department of Immunology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
  • Liu Y; Division of Oncology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.
  • Zheng P; Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis School of Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA.
Signal Transduct Target Ther ; 7(1): 224, 2022 07 15.
Article in English | MEDLINE | ID: covidwho-2008258
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune System Diseases / Neoplasms Type of study: Experimental Studies Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01030-x

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune System Diseases / Neoplasms Type of study: Experimental Studies Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-01030-x